These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6365372)

  • 1. Glomerular & vascular changes in malignant hypertension.
    Kincaid-Smith P; Owen J; Whitworth JA; Walter MA; Doyle A; Woods RA
    Clin Exp Hypertens A; 1984; 6(1-2):471-91. PubMed ID: 6365372
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of heparin and defibrinotide on malignant hypertension in rats.
    Kamitsuji H; Whitworth J; Kincaid-Smith P
    Clin Exp Hypertens A; 1986; 8(6):1009-32. PubMed ID: 3530562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripolar cells, granulated glomerular epithelial cells, and their relationship to the juxtaglomerular apparatus in malignant hypertension.
    Gardiner DS; Lindop GB
    J Pathol; 1992 May; 167(1):59-64. PubMed ID: 1625059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anatomic pathology and pathogenesis of the lesions of small arteries and arterioles of the kidney in essential hypertension.
    Mandal AK; Bell RD; Nordquist JA; Lindeman RD
    Pathol Annu; 1977; 12 Pt 1():331-71. PubMed ID: 917596
    [No Abstract]   [Full Text] [Related]  

  • 5. Participation of intravascular coagulation in the pathogenesis of glomerular and vascular lesions.
    Kincaid-Smith P
    Kidney Int; 1975 Apr; 7(4):242-53. PubMed ID: 1142640
    [No Abstract]   [Full Text] [Related]  

  • 6. High arterial pressure versus humoral factors in the pathogenesis of the vascular lesions of malignant hypertension.
    Beilin LJ; Goldby FS; Mohring J
    Clin Sci Mol Med; 1977 Feb; 52(2):111-7. PubMed ID: 844244
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal vascular and tubulointerstitial inflammation and proliferation in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
    Graciano ML; Mouton CR; Patterson ME; Seth DM; Mullins JJ; Mitchell KD
    Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1858-66. PubMed ID: 17344186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular lesions and angiotensin in malignant hypertension in the absence of vasopressin.
    Woods RL; Abrahams JM; Kincaid-Smith P; Johnston CI
    Clin Exp Pharmacol Physiol; 1982; 9(3):297-301. PubMed ID: 6754178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathological analysis of malignant nephrosclerosis].
    Hoshi S; Yamaguchi Y; Sanaka T; Hosoya T
    Nihon Jinzo Gakkai Shi; 2008; 50(4):488-98. PubMed ID: 18546880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myosin content and vasoconstrictive ability of the proximal and distal (renin-positive) segments of the preglomerular arteriole.
    Taugner R; Rosivall L; Bührle CP; Gröschel-Stewart U
    Cell Tissue Res; 1987 Jun; 248(3):579-88. PubMed ID: 3300994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hypertension in blacks. Malignant intrarenal arterial disease as observed by light and electron microscopy.
    Pitcock JA; Johnson JG; Hatch FE; Acchiardo S; Muirhead EE; Brown PS
    Hum Pathol; 1976 May; 7(3):333-46. PubMed ID: 1270065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant hypertension in Brattleboro (vasopressin-deficient) rats.
    Woods RL; Abrahams JM; Kincaid-Smith P; Johnston CI
    J Hypertens; 1983 Jun; 1(1):37-43. PubMed ID: 6397512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats.
    Li JS; Schürch W; Schiffrin EL
    Am J Hypertens; 1996 Aug; 9(8):803-11. PubMed ID: 8862227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute arterial fibrinoid deposition and ischaemic parenchymal damage of the kidney. Pathogenic factors in the development of malignant hypertension.
    Chatelain RE; Dardik BN; Shainoff JR
    J Pathol; 1983 Oct; 141(2):125-42. PubMed ID: 6363644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kidney in progressive systemic sclerosis (scleroderma).
    Dichoso CC
    Perspect Nephrol Hypertens; 1976; 3():57-74. PubMed ID: 765954
    [No Abstract]   [Full Text] [Related]  

  • 16. Arterial and glomerular lesions associated with severe hypertension. Light and electron microscopic studies.
    Jones DB
    Lab Invest; 1974 Oct; 31(4):303-13. PubMed ID: 4412080
    [No Abstract]   [Full Text] [Related]  

  • 17. [Malignant arterial hypertension caused by segmentary aglomerular hypoplasia. Study of the activity of plasma renin].
    Fernández-Andrade CM; Martínez Martin A; Maceira Cruz B; Mendoza Llera M; Mateos Aguilar J; Quereda Rodríguez-Navarro C; Martin Alburquerque L; Fernández Alonso J
    Rev Clin Esp; 1977 Jun; 145(5):375-80. PubMed ID: 877350
    [No Abstract]   [Full Text] [Related]  

  • 18. Fine structural appearances of glomerular capillaries in a case of malignant hypertension.
    Macadam RF
    J Clin Pathol; 1969 Sep; 22(5):579-83. PubMed ID: 5364444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal proliferative arteriopathies and associated glomerular changes: a light and electron microscopic study.
    Sinclair RA; Antonovych TT; Mostofi FK
    Hum Pathol; 1976 Sep; 7(5):565-88. PubMed ID: 987010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant arterial hypertension and chronic renal insufficiency: anatomoclinical correlations].
    Ianhez LE; Saldanha LB; Sabbaga E
    Rev Hosp Clin Fac Med Sao Paulo; 1978 Aug; 33(4):180-3. PubMed ID: 725418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.